Literature DB >> 22927087

Myocarditis: diagnosis and treatment.

Maya Guglin1, Leelakrishna Nallamshetty.   

Abstract

OPINION STATEMENT: Myocarditis is a condition that can have a very wide clinical spectrum ranging from asymptomatic forms to fatal disease, but mostly presenting as new onset heart failure with reduced left ventricular ejection fraction, with or without viral syndrome. This condition is an important cause of sudden cardiac death in young patients. High risk features include second and third degree atrioventricular block or malignant arrhythmias. The diagnostic work-up may be challenging, but non-invasive imaging, primarily cardiac magnetic resonance, plays an increasingly important role, although endomyocardial biopsy is still considered a gold standard for diagnosis. Most importantly, myocarditis can transition to non-ischemic cardiomyopathy with eventually poor outcome. In this review, we will summarize the data on different diagnostic and treatment modalities of this disease.

Entities:  

Year:  2012        PMID: 22927087     DOI: 10.1007/s11936-012-0204-7

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  64 in total

1.  Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis.

Authors:  Philipp Lurz; Ingo Eitel; Julia Adam; Julia Steiner; Matthias Grothoff; Steffen Desch; Georg Fuernau; Suzanne de Waha; Mahdi Sareban; Christian Luecke; Karin Klingel; Reinhard Kandolf; Gerhard Schuler; Matthias Gutberlet; Holger Thiele
Journal:  JACC Cardiovasc Imaging       Date:  2012-05

2.  Myocarditis. A histopathologic definition and classification.

Authors:  H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

3.  Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome.

Authors:  D W Anderson; R Virmani; J M Reilly; T O'Leary; R E Cunnion; M Robinowitz; A M Macher; U Punja; S T Villaflor; J E Parrillo
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

4.  Direct T2 quantification of myocardial edema in acute ischemic injury.

Authors:  David Verhaert; Paaladinesh Thavendiranathan; Shivraman Giri; Georgeta Mihai; Sanjay Rajagopalan; Orlando P Simonetti; Subha V Raman
Journal:  JACC Cardiovasc Imaging       Date:  2011-03

5.  Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders.

Authors:  Andrea Frustaci; Cristina Chimenti; Fiorella Calabrese; Maurizio Pieroni; Gaetano Thiene; Attilio Maseri
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

6.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

7.  Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.

Authors:  H J Why; B T Meany; P J Richardson; E G Olsen; N E Bowles; L Cunningham; C A Freeke; L C Archard
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

8.  Sudden unexpected death in persons less than 40 years of age.

Authors:  Y Drory; Y Turetz; Y Hiss; B Lev; E Z Fisman; A Pines; M R Kramer
Journal:  Am J Cardiol       Date:  1991-11-15       Impact factor: 2.778

9.  Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.

Authors:  Uwe Kühl; Matthias Pauschinger; Peter Lothar Schwimmbeck; Bettina Seeberg; Conny Lober; Michel Noutsias; Wolfgang Poller; Heinz-Peter Schultheiss
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

10.  The TandemHeart pVAD in the treatment of acute fulminant myocarditis.

Authors:  Wissam I Khalife; Biswajit Kar
Journal:  Tex Heart Inst J       Date:  2007
View more
  15 in total

Review 1.  PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism.

Authors:  Hao Dong; Yihang Qi; Xiangyi Kong; Zhongzhao Wang; Yi Fang; Jing Wang
Journal:  Front Pharmacol       Date:  2022-04-19       Impact factor: 5.988

2.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16

3.  Heart Failure in Chronic Myocarditis: A Role for microRNAs?

Authors:  P van den Hoogen; F van den Akker; J C Deddens; J P G Sluijter
Journal:  Curr Genomics       Date:  2015-04       Impact factor: 2.236

4.  Myocarditis, hepatitis, and pancreatitis in a patient with coxsackievirus A4 infection: a case report.

Authors:  Nobuhiro Akuzawa; Naoyuki Harada; Takashi Hatori; Kunihiko Imai; Yonosuke Kitahara; Shinji Sakurai; Masahiko Kurabayashi
Journal:  Virol J       Date:  2014-01-13       Impact factor: 4.099

5.  AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.

Authors:  Liang Yin; Dafei Chai; Yan Yue; Chunsheng Dong; Sidong Xiong
Journal:  Front Cell Infect Microbiol       Date:  2017-06-08       Impact factor: 5.293

6.  Theiler's Virus-Mediated Immunopathology in the CNS and Heart: Roles of Organ-Specific Cytokine and Lymphatic Responses.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Alireza Minagar; Mahmoud Al-Kofahi; J Winny Yun; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Front Immunol       Date:  2018-12-10       Impact factor: 7.561

Review 7.  Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management.

Authors:  Yu-Wen Zhou; Ya-Juan Zhu; Man-Ni Wang; Yao Xie; Chao-Yue Chen; Tao Zhang; Fan Xia; Zhen-Yu Ding; Ji-Yan Liu
Journal:  Front Pharmacol       Date:  2019-11-29       Impact factor: 5.810

Review 8.  A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis.

Authors:  Adedayo Adeboye; Deya Alkhatib; Asra Butt; Neeraja Yedlapati; Nadish Garg
Journal:  Diagnostics (Basel)       Date:  2022-02-21

9.  Intravenous immunoglobulin for presumed viral myocarditis in children and adults.

Authors:  Joan Robinson; Lisa Hartling; Ben Vandermeer; Meghan Sebastianski; Terry P Klassen
Journal:  Cochrane Database Syst Rev       Date:  2020-08-19

10.  Effect of PKC inhibitor on experimental autoimmune myocarditis in Lewis rats.

Authors:  Chunlian Zhong; Yang Wu; He Chang; Chunxiao Liu; Li Zhou; Jun Zou; Zhi Qi
Journal:  Oncotarget       Date:  2017-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.